BSEKabra Drugs LtdMinimalNeutral
Announced Tue, 6 Jan · 13:11 IST

Certificate pursuant to Regulations 74 (5)

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kabra Drugs Ltd has submitted a compliance certificate from its Registrar and Share Transfer Agent, Skyline Financial Services Pvt Ltd, for the quarter ended 31st December 2025. The certificate confirms that physical share certificates received for dematerialization were duly verified, mutilated, cancelled, and the depository's name was substituted as the registered owner in the company's records within 15 days. The filing is a routine regulatory requirement under SEBI's Depositories and Participants Regulations. Signed by Managing Director Nanjappan Aravind on 6th January 2026.

Likely market impact

This is a standard quarterly compliance filing with no material impact on the company's financials, operations, or stock price. It merely confirms procedural adherence to dematerialization norms.